Announcements Trials

Browse Landscape

Sponsor

Conditions

Breast Neoplasms 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Lung Neoplasms 3 Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Non-Small Cell Lung Cancer Metastatic 1 Neoplasms 1 Melanoma 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Endometrial Neoplasms 1

Interventions

Bevacizumab 32 Cetuximab 28 Fluorouracil 26 Leucovorin 24 Specimen Handling 23 Oxaliplatin 23 pembrolizumab 18 Biopsy 16 Magnetic Resonance Spectroscopy 14 Irinotecan 13 Nivolumab 9 atezolizumab 7 Folfox protocol 7 fludarabine 6 balstilimab 6 Pemetrexed 6 Panitumumab 6 Cyclophosphamide 6 Cisplatin 6 Carboplatin 6 Capecitabine 6 trifluridine tipiracil drug combination 5 encorafenib 5 Standard of Care 5 IFL protocol 5 HMPL-013 5 Gemcitabine 5 dehydroftorafur 4 Immunoglobulin G 4 Disulfides 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Colorectal Neoplasms × patritumab deruxtecan × 30 days × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡